» Articles » PMID: 21134381

Dynamic Conformations of the CD38-mediated NAD Cyclization Captured in a Single Crystal

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2010 Dec 8
PMID 21134381
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The extracellular domain of human CD38 is a multifunctional enzyme involved in the metabolism of two Ca(2+) messengers: cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate. When NAD is used as substrate, CD38 predominantly hydrolyzes it to ADP-ribose, with a trace amount of cyclic ADP-ribose produced through cyclization of the substrate. However, mutation of a key residue at the active site, E146, inhibits the hydrolysis activity of CD38 but greatly increases its cyclization activity. To understand the role of the residue E146 in the catalytic process, we determined the crystal structure of the E146A mutant protein with a substrate analogue, arabinosyl-2'-fluoro-deoxy-nicotinamide adenine dinucleotide. The structure captured the enzymatic reaction intermediates in six different conformations in a crystallographic asymmetric unit. The structural results indicate a folding-back process for the adenine ring of the substrate and provide the first multiple snapshots of the process. Our approach of utilizing multiple molecules in the crystallographic asymmetric unit should be generally applicable for capturing the dynamic nature of enzymatic catalysis.

Citing Articles

Resolving the topological enigma in Ca signaling by cyclic ADP-ribose and NAADP.

Lee H, Zhao Y J Biol Chem. 2019; 294(52):19831-19843.

PMID: 31672920 PMC: 6937575. DOI: 10.1074/jbc.REV119.009635.


A Cell-Permeant Mimetic of NMN Activates SARM1 to Produce Cyclic ADP-Ribose and Induce Non-apoptotic Cell Death.

Zhao Z, Xie X, Li W, Liu J, Chen Z, Zhang B iScience. 2019; 15:452-466.

PMID: 31128467 PMC: 6531917. DOI: 10.1016/j.isci.2019.05.001.


Synthetic cADPR analogues may form only one of two possible conformational diastereoisomers.

Watt J, Thomas M, Potter B Sci Rep. 2018; 8(1):15268.

PMID: 30323284 PMC: 6189198. DOI: 10.1038/s41598-018-33484-x.


Immuno-targeting the multifunctional CD38 using nanobody.

Li T, Qi S, Unger M, Hou Y, Deng Q, Liu J Sci Rep. 2016; 6:27055.

PMID: 27251573 PMC: 4890012. DOI: 10.1038/srep27055.


Porcine CD38 exhibits prominent secondary NAD(+) cyclase activity.

Ting K, Leung C, Graeff R, Lee H, Hao Q, Kotaka M Protein Sci. 2015; 25(3):650-61.

PMID: 26660500 PMC: 4815406. DOI: 10.1002/pro.2859.


References
1.
Thornton P, Fernandez C, Giustolisi G, Morilla R, Atkinson S, AHern R . CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia. Hematol J. 2004; 5(2):145-51. DOI: 10.1038/sj.thj.6200360. View

2.
Lee H, Munshi C, Graeff R . Structures and activities of cyclic ADP-ribose, NAADP and their metabolic enzymes. Mol Cell Biochem. 1999; 193(1-2):89-98. DOI: 10.1007/978-1-4419-8740-2_13. View

3.
Damle R, Wasil T, Fais F, Ghiotto F, Valetto A, Allen S . Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999; 94(6):1840-7. View

4.
Lee H . A unified mechanism of enzymatic synthesis of two calcium messengers: cyclic ADP-ribose and NAADP. Biol Chem. 1999; 380(7-8):785-93. DOI: 10.1515/BC.1999.098. View

5.
Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein A, Ortolan E . Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev. 2008; 88(3):841-86. DOI: 10.1152/physrev.00035.2007. View